Gonorrhoea and syphilis hit record levels in Europe
Gonorrhoea and Syphilis Hit Record Levels in Europe
Gonorrhoea and syphilis hit record levels – Sexually transmitted infections (STIs) are currently on the rise across Europe, with gonorrhoea and syphilis cases reaching their highest numbers in over a decade. The European Centre for Disease Prevention and Control (ECDC) recently highlighted this alarming trend, noting that both diseases experienced unprecedented outbreaks in 2024. This surge has raised concerns among health officials, who are calling for immediate measures to address the growing crisis.
Unprecedented Growth in Infections
The ECDC’s latest findings reveal that gonorrhoea cases in Europe climbed to 106,331 in 2024, representing a 303% increase since 2015. Syphilis followed a similar trajectory, with its total cases nearly doubling to 45,557 over the same period. These statistics mark a significant departure from previous years, indicating a rapid acceleration in the spread of these infections. The agency emphasized that the rise in cases is not just a numerical anomaly but a critical public health issue demanding attention.
According to the ECDC, the primary drivers behind this surge include disparities in access to testing and prevention strategies. “The widening gap in testing and prevention efforts has contributed to the sharp increase in infections,” stated Bruno Ciancio, head of the agency’s Directly Transmitted and Vaccine-Preventable Diseases unit. He further warned that untreated STIs can lead to severe long-term health consequences, such as chronic pain, infertility, and complications affecting the heart or nervous system.
“Protecting your sexual health remains straightforward. Use condoms with new or multiple partners, and get tested if you have symptoms.”
Among the most concerning developments is the rise in congenital syphilis cases. These instances, where infections are transmitted directly from mother to child, have nearly doubled from 2023 to 2024. This trend underscores the potential for lifelong health issues in newborns, including neurological and cardiac problems, and highlights the urgency of addressing maternal STI prevention programs.
Spain Leads in Cases
Spain emerged as the European country with the most confirmed gonorrhoea and syphilis cases in 2024. The nation reported 37,169 gonorrhoea cases and 11,556 syphilis cases, surpassing other participating countries in the ECDC’s analysis. Health authorities in Spain are now under pressure to implement targeted interventions to stem the spread of these infections, particularly in high-risk populations.
While gonorrhoea and syphilis dominate the headlines, chlamydia remains the most commonly diagnosed bacterial STI in Europe. However, recent data shows a 6% decline in chlamydia cases since 2015, with 213,443 diagnoses recorded in 2024. This reduction suggests that some preventive measures have had a positive impact, but it does not negate the urgency of addressing the rising cases of gonorrhoea and syphilis.
UK’s Separate Trends
Although the UK is no longer part of the ECDC’s collaborative data collection since Brexit, its own national figures provide insight into the regional spread of STIs. In England alone, the UK Health Security Agency reported 71,802 gonorrhoea cases in 2024 and 9,535 syphilis cases during the same period. Chlamydia diagnoses also totaled 168,889 in 2024, reflecting a complex picture of infection trends within the country.
The UK’s response to the gonorrhoea epidemic has been proactive. In 2023, the nation reached a record high of 85,000 gonorrhoea cases, prompting the government to launch a vaccination program in 2025. This initiative aims to reduce the burden of the disease and curb its spread through immunization. Syphilis, meanwhile, continues to pose challenges, with its cases remaining a focus of public health campaigns.
Experts argue that the combination of changing sexual behaviors, reduced condom use, and limited access to testing is exacerbating the STI crisis. The ECDC’s report highlights the need for improved education and outreach, particularly in younger demographics and among marginalized communities. Without swift action, the situation could worsen, leading to increased morbidity and mortality rates.
Public health officials stress that early detection and treatment are crucial in mitigating the impact of STIs. The rise in congenital syphilis cases, for instance, underscores the importance of prenatal screening and timely interventions. As the data shows, the consequences of untreated infections extend beyond individuals, affecting entire families and communities.
While the ECDC’s report provides a broad overview of Europe’s STI landscape, national variations highlight the need for localized strategies. Spain’s high case numbers suggest that targeted efforts are essential to tackle the issue effectively. In contrast, the UK’s focus on vaccination for gonorrhoea demonstrates a different approach to combating the spread of these infections.
With both gonorrhoea and syphilis reaching record levels, the health landscape in Europe is shifting. The ECDC’s warning serves as a call to action for policymakers and healthcare providers to invest in prevention, testing, and education. By addressing the root causes of the surge, Europe can work toward reversing the trend and protecting its population from the long-term effects of these diseases.
As the data from 2024 continues to shape public health discussions, it is clear that the fight against STIs requires sustained commitment. The ECDC’s report not only highlights the severity of the current situation but also emphasizes the importance of collaboration and innovation in combating these infections. Without urgent measures, the record levels of gonorrhoea and syphilis may become a new norm, impacting millions of lives across the continent.